Solid Biosciences a new Outperform at William Blair on Duchenne asset
at seekingalpha.com (Mon, 9-Nov 4:10 PM)
Solid Biosciences Highlights EU Orphan Designation for SGT-212 as FALCON Trial Reaches Five Dosed Patients
Market Chameleon (Mon, 26-Oct 8:11 AM)
SLDB gains as Solid Biosciences lines up seven ESGCT 2026 posters spanning SGT-003, POLARIS-101, and manufacturing
Market Chameleon (Tue, 20-Oct 11:26 AM)
